Stribild is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Elvitegravir; Cobicistat; Emtricitabine; Tenofovir Disoproxil Fumarate.
| Product ID | 61958-1201_8c36d9fb-28e9-4d73-851b-968d9752a3d4 |
| NDC | 61958-1201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Stribild |
| Generic Name | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-08-27 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203100 |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
| Active Ingredient Strength | 150 mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2012-08-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA203100 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-08-27 |
| Ingredient | Strength |
|---|---|
| ELVITEGRAVIR | 150 mg/1 |
| SPL SET ID: | 74ae2a93-b267-444c-8f0f-a2a6522260ee |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-1318 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
| 53808-0887 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
| 61958-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
| 69189-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
| 70518-0674 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() STRIBILD 85688699 4320307 Live/Registered |
GILEAD SCIENCES IRELAND UC 2012-07-27 |
![]() STRIBILD 85555217 4263613 Live/Registered |
GILEAD SCIENCES IRELAND UC 2012-02-28 |